{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:42:47Z","timestamp":1772883767609,"version":"3.50.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T00:00:00Z","timestamp":1562630400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s13063-019-3517-y","type":"journal-article","created":{"date-parts":[[2019,7,9]],"date-time":"2019-07-09T14:14:22Z","timestamp":1562681662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Glibenclamide in aneurysmatic subarachnoid hemorrhage (GASH): study protocol for a randomized controlled trial"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7746-213X","authenticated-orcid":false,"given":"Bruno Braga Sisnando","family":"da Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabela Costola","family":"Windlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edwin","family":"Koterba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitor Nagai","family":"Yamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N\u00edcollas Nunes","family":"Rabelo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davi Jorge Fontoura","family":"Solla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manoel Jacobsen","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eberval Gadelha","family":"Figueiredo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,9]]},"reference":[{"key":"3517_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(09)70025-0","volume":"8","author":"VL Feigin","year":"2009","unstructured":"Feigin VL, Lawes CMM, Bennett DA, Barker-callo SL, Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol. 2009;8:355\u201369.","journal-title":"Lancet Neurol"},{"key":"3517_CR2","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.1161\/01.STR.31.8.1843","volume":"31","author":"The Across Group","year":"2000","unstructured":"The Across Group. Epidemiology of aneurysmal subarachnoid hemorrhage in Australia and New Zealand. Incidence and case fatality from the Australasian Cooperative Research on Subarachnoid Hemorrhage Study (ACROSS). Stroke. 2000;31:1843\u201350.","journal-title":"Stroke"},{"key":"3517_CR3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0140-6736(07)60153-6","volume":"369","author":"J Van Gijn","year":"2007","unstructured":"Van Gijn J, Kerr RS, Rinkel GJ. Subarachnoid hemorrhage. Lancet. 2007;369:306\u201318.","journal-title":"Lancet"},{"key":"3517_CR4","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/S0140-6736(05)67214-5","volume":"366","author":"AJ Molyneux","year":"2005","unstructured":"Molyneux AJ, Kerr RSC, Yu LM, et al. International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysms: a randomized comparison of effects on survival, dependency, seizures, rebleeding, subgroups and aneurysm occlusion. Lancet. 2005;366:809\u201317.","journal-title":"Lancet"},{"key":"3517_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nrneurol.2013.246","volume":"10","author":"RL Macdonald","year":"2014","unstructured":"Macdonald RL. Delayed neurological deterioration after subarachnoid hemorrhage. Nat Rev Neurol. 2014;10:44\u201358.","journal-title":"Nat Rev Neurol"},{"key":"3517_CR6","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/S1474-4422(11)70108-9","volume":"10","author":"RL Macdonald","year":"2011","unstructured":"Macdonald RL, Higashida RT, Keller E, et al. Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid hemorrhage undergoing surgical clipping: a randomized, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2). Lancet Neurol. 2011;10:618\u201325.","journal-title":"Lancet Neurol"},{"key":"3517_CR7","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1161\/01.STR.0000160801.96998.57","volume":"36","author":"W Van den bergh","year":"2005","unstructured":"Van den bergh W. Magnesium sulfate in aneurysmal subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2005;36:1011\u20135.","journal-title":"Stroke"},{"key":"3517_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.3171\/jns.2000.93.6.0992","volume":"93","author":"MDM Shaw","year":"2000","unstructured":"Shaw MDM, Vermeulen M, Murray GD, Pickard JD, Bell BA, Teasdale GM. Efficacy and safety of the endothelinA\/B receptor antagonist TAK-044 in treating subarachnoid hemorrhage: a report by the Steering Committee on behalf of the UK\/Netherlands\/Eire TAK-044 subarachnoid hemorrhage study group. J Neurosurg. 2000;93:992\u20137.","journal-title":"J Neurosurg"},{"key":"3517_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/571328","volume":"2013","author":"Ioannis Siasios","year":"2013","unstructured":"Siasios I, Kapsalaki EZ, Fountas KN. Cerebral vasospasm pharmacological treatment: an update. Neurol Res Int. 2013;2013(ID 571328):1\u201320.","journal-title":"Neurology Research International"},{"key":"3517_CR10","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3171\/jns.1997.86.3.0467","volume":"86","author":"EC Haley","year":"1997","unstructured":"Haley EC, Kassel NF, Apperson-hansen C, Maile MH, Alves WM. A randomised double-blind, vehicle-controlled trial of tirilazad mesylate in patients with aneurysmal subarachnoid hemorrhage: a cooperative study in North America. J Neurosurg. 1997;86:467\u201374.","journal-title":"J Neurosurg"},{"key":"3517_CR11","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1136\/bmj.298.6674.636","volume":"298","author":"JD Pickard","year":"1989","unstructured":"Pickard JD, Murray GD, Illingworth R, et al. Effect of oral nimodipine on cerebral infarction and outcome after subarachnoid hemorrhage: British aneurysm nimodipine trial. BMJ. 1989;298:636\u201342.","journal-title":"BMJ"},{"key":"3517_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1093\/brain\/124.2.249","volume":"124","author":"J Van gijn","year":"2001","unstructured":"Van gijn J, Rinkel GJE. Subarachnoid hemorrhage: diagnosis, causes and management. Brain. 2001;124:249\u201378.","journal-title":"Brain"},{"key":"3517_CR13","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1007\/s11940-012-0163-z","volume":"14","author":"R Dhar","year":"2012","unstructured":"Dhar R, Diringer M. Statins and anti-inflammatory therapies for subarachnoid hemorrhage. Curr Treat Options Neurol. 2012;14:164\u201374.","journal-title":"Curr Treat Options Neurol"},{"key":"3517_CR14","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1161\/01.STR.0000176743.67564.5d","volume":"36","author":"MY Tseng","year":"2005","unstructured":"Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage. A phase 11 randomised placebo-controlled trial. Stroke. 2005;36:1627\u201332.","journal-title":"Stroke"},{"key":"3517_CR15","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.3171\/JNS-07\/12\/1092","volume":"107","author":"MY Tseng","year":"2007","unstructured":"Tseng MY, Hutchinson PJA, Turner CL, et al. Biological effects of acute pravastatin treatment in patients after aneurysmal subarachnoid hemorrhage: a double-blind placebo-controlled trial. J Neurosurg. 2007;107:1092\u2013100.","journal-title":"J Neurosurg"},{"issue":"10","key":"3517_CR16","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.3390\/ph6101287","volume":"6","author":"DB Kurland","year":"2013","unstructured":"Kurland DB, Tosun C, Pampori A, Karimy JK, Caffes NM, Gerzanich V, Simard JM. Glibenclamide for the treatment of acute CNS injury. Pharmaceuticals (Basel). 2013;6(10):1287\u2013303.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"9","key":"3517_CR17","doi-asserted-by":"publisher","first-page":"2526","DOI":"10.1161\/STROKEAHA.107.482216","volume":"38","author":"HL Kunte","year":"2007","unstructured":"Kunte HL, Schmidt S, Eliasziw M, Del zoppo GJ, Simard JM, Masuhr F, Weih M, Dirnagl U. Sulfonylureas improve outcome in patients with type 2 diabetes and acute ischemic stroke. Stroke. 2007;38(9):2526\u201330.","journal-title":"Stroke"},{"issue":"12","key":"3517_CR18","doi-asserted-by":"publisher","first-page":"3522","DOI":"10.1161\/STROKEAHA.113.002904","volume":"44","author":"C Tosun","year":"2013","unstructured":"Tosun C, Kurland DB, Mehta R, Castellani RJ, Dejong JL, Kwon MS, Woo SK, Gerzanich V, Simard JM. Inhibition of the Sur1-Trpm4 channel reduces neuroinflammation and cognitive impairment in subarachnoid hemorrhage. Stroke. 2013;44(12):3522\u20138.","journal-title":"Stroke"},{"key":"3517_CR19","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/jcbfm.2008.120","volume":"29","author":"JM Simard","year":"2013","unstructured":"Simard JM, Geng Z, Woo SK, Ivanova S, Tosun C, Melnichenko L, Gerzanich V. Glibenclamide reduces inflammation, vasogenic edema, and caspase-3 activation after subarachnoid hemorrhage. J Cereb Blood Flow Metab. 2013;29:317\u201330.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3517_CR20","unstructured":"Eisenberg E, Banshal V. Glyburide (RP-1127) for traumatic brain injury (TBI). Available from: \n                    http:\/\/clinicaltrials.gov\/show\/NCT01454154\n                    \n                  . Accessed 6 May 2015."},{"key":"3517_CR21","unstructured":"Sheth KN, Kimberly WT. Safety study of RP-1127 (glyburide for injection) in healthy volunteers. Available from: \n                    http:\/\/clinicaltrials.gov\/show\/NCT01132703\n                    \n                  . Accessed 4 June 2014."},{"key":"3517_CR22","unstructured":"Sheth KN, Kimberly WT. Glyburide advantage in malignant edema and stroke-remedy pharmaceuticals (GAMES-RP). Available from: \n                    http:\/\/clinicaltrials.gov\/show\/NCT01794182\n                    \n                  . Accessed 2 June 2015."},{"key":"3517_CR23","unstructured":"Sheth KN. Glyburide advantage in malignant edema and stroke pilot (GAMES-PILOT). Available from: \n                    http:\/\/clinicaltrials.gov\/show\/NCT01268683\n                    \n                  . Accessed 6 June 2014."},{"key":"3517_CR24","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s12975-016-0506-2","volume":"8","author":"B Jiang","year":"2017","unstructured":"Jiang B, Li L, Chen Q, Tao Y, Yang L, Zhang B, Zhang JH, Feng H, Chen Z, Tang J, Zhu G. Role of glibenclamide in brain injury after intracerebral hemorrhage. Transl Stroke Res. 2017;8:183\u201393.","journal-title":"Transl Stroke Res"},{"issue":"10","key":"3517_CR25","doi-asserted-by":"publisher","first-page":"2391","DOI":"10.1161\/STROKEAHA.110.589275","volume":"41","author":"MDI Vergouwen","year":"2010","unstructured":"Vergouwen MDI, Vermeulen M, van Gijn J, Rinkel GJE, Wijdicks EF, Muizelaar JP, Mendelow AD, Juvela S, Yonas H, Terbrugge KG, Macdonald RL, Diringer MN, Broderick JP, Dreier JP, Roos YBWEM. Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke. 2010;41(10):2391\u20135.","journal-title":"Stroke"},{"key":"3517_CR26","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1097\/NEN.0b013e3181fbf6d6","volume":"69","author":"AD Patel","year":"2010","unstructured":"Patel AD, Gerzanich V, Geng Z, Simard JM. Glibenclamide reduces hippocampal injury and preserves rapid spatial learning in a model of traumatic brain injury. J Neuropathol Exp Neurol. 2010;69:1177\u201390.","journal-title":"J Neuropathol Exp Neurol"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13063-019-3517-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-019-3517-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,7]],"date-time":"2020-07-07T23:17:37Z","timestamp":1594163857000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-019-3517-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["3517"],"URL":"https:\/\/doi.org\/10.1186\/s13063-019-3517-y","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,9]]},"assertion":[{"value":"11 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Appropriate ethics and regulatory approval were sought for all subjects, according to the International Conference on Harmonization guidelines for good clinical practice (ICH GCP). We will obtain informed written consent from all patients or their legal representatives. This study has the ethics approval of the Brazilian Health Ministry by \u201cPlataforma Brasil\u201d () under the number CAAE:55947016.2.0000.0068.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All participants consented to data publication. All individual privacy is preserved.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"413"}}